Evidence map›Paper›PMID 12777693›Full record

ReviewMolecular biotechnology2003

A new look at xylanases: an overview of purification strategies.

Paula Sá-Pereira, Helena Paveia, Maria Costa-Ferreira, Maria Aires-Barros

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paula Sá-PereiraDepartment of Biotechnology, Unit of Bioengineering and Bioprocesses, Estrada do Pago do Luminar. 22, Edifícia F Sala 1070A, 1649-038, Lisboa, Portugal. paula.pereira@inet.pt
Helena Paveia
Maria Costa-Ferreira
Maria Aires-Barros
Institute for Biotechnology and Bioengineering · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in xylanases from different sources has increased markedly in the past decade, in part because of the application of these enzymes in the pulp and paper industry. Purity and purification costs are becoming important issues in modern biotechnology as the industry matures and competitive products reach the marketplace. Thus, new paths for successful and efficient xylanase recovery have to be followed. This article reviews the isolation and purification methods used for the recovery of microbial xylanases. Origins and applications of xylanases are described, highlighting the special features of this class of enzymes, such as the carbohydrate-binding domains (CBDs) and their importance in the development of affinity methodologies to increase and facilitate xylanase purification. Implications of recombinant DNA technology for the isolation and purification of xylanases are evaluated. Several purification procedures are analyzed, taking into consideration the sequence of the methods used in each and the number of times each method is used. New directions to improve xylanase separation and purification from fermentation media are described.

Indexed as

BacteriaBiotechnologyCloning, MolecularDNA, RibosomalEndo-1,4-beta XylanasesPlantsRecombinant ProteinsWoodDNA, RibosomalEndo-1,4-beta XylanasesRecombinant Proteins

Identifiers

PMID12777693
OpenAlexW2034765206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.